Reporter plasmid of human TOP2A-3'-UTR region for quantitatively evaluate miRNA activity.
Clone info. | Reporter plasmid of human topoisomerase 2 alpha (TOP2A)-3'-UTR region for quantitatively evaluate miRNA activity. |
---|---|
Comment | Expression was confirmed by the depositor with reporter assay. |
Vector backbone | pmirGLO (plasmid) |
Size of vector backbone | 7.4 kb |
Selectable markers | Amp^r |
Gene/insert name | human TOP2A cDNA |
Depositor|Developer | Kondo, Yutaka | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() MTA, for use for for-profit purpose [Word ![]() Approval form by depositor [Word ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested. (Katsushima, K et al. Nat. Commun. 7: 13616, 2016); (Deguchi, S et al. Oncogene. 36 (32) : 4629 - 4640, 2017). RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
Remarks | ((Additional form)) Approval Form(FormD) Please obtain written approval of the depositor. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 提供同意書 (MTA, 営利目的用)[Word ![]() 寄託者による提供承諾書 [Word ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 利用者は提供承諾書を用いて、事前に寄託者の承諾を得る。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Katsushima, K et al. Nat. Commun. 7: 13616, 2016); (Deguchi, S et al. Oncogene. 36 (32) : 4629 - 4640, 2017)。利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び事業活動を行う場合は、寄託者と別途協議を行う。営利機関の利用希望者は、事前に利用条件等につき寄託者と合意し、提供承諾を得ること。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
備考 | 【追加提供依頼書】承諾書(FormD) 寄託者の書面による提供承諾が必要です。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB15800 | pmirGLO-TOP2A-3'-UTR | DNA solution |
JPY 9,460 (not-for-profit academic purpose) JPY 18,920 (for-profit-research purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pmirGLO-TOP2A-3'-UTR was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB15800). |
Reference section:
Deguchi, S., Katsushima, K., Hatanaka, A., Shinjo, K., Ohka, F., Wakabayashi, T., Zong, H., Natsume, A., Kondo, Y., Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis. Oncogene 36 (32): 4629-4640 (2017). PMID 28368417. [link to RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB15800_A8Bqp1-1.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: luc2-c_F (Pr0546) Region: Luc 2 3',insert 5' Sequence file: RDB15800_A8Bqa.seq ![]() |
---|
>D05196A7-4_A8Bq_luc2-C_F_D02_2018-03-19-14-24-28_11.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNGNNNNT CTCNTTAAGG CCNAGAAGGG CGGCAAGATC 61 GCCGTGTAAT TCTAGTTGTT TAAACGAGCT CGCTAGCCTC GAGAATGTGA GGCGATTATT 121 TTAAGTAATT ATCTTACCAA GCCCAAGACT GGTTTTAAAG TTACCTGAAG CTCTTAACTT 181 CCTCCCCTCT GAATTTAGTT TGGGGAAGGT GTTTTTAGTA CAAGACATCA AAGTGAAGTA 241 AAGCCCAAGT GTTCTTTAGC TTTTTATAAT ACTGTCTAAA TAGTGACCAT CTCATGGGCA 301 TTGTTTTCTT CTCTGCTTTG TCTGTGTTTT GAGTCTGCTT TCTTTTGTCT TTAAAACCTG 361 ATTTTTAAGT TCTTCTGAAC TGTAGAAATA GCTATCTGAT CACTTCAGCG TAAAGCAGTG 421 TGTTTATTAA CCATCCACTA AGCTAAAACT AGAGCAGTTT GATTTAAAAG TGTCACTCTT 481 CCTCCTTTTC TACTTTCAGT AGATATGAGA TAGAGCATAA TTATCTGTTT TATCTTAGTT 541 TTATACATAA TTTACCATCA GATAGAACTT TATGGTTCTA GTACAGATAC TCTACTACAC 601 TCAGCCTCTT ATGTGCCAAG TTTTTCTTTA AGCAATGAGA AATTGCTCAT GTTCTTCATC 661 TTCTCAAATC ATCAGAGGCC GAAGAAAAAC ACTTTGGCTG TGTCTATAAC TTGACACAGT 721 CAATAGAATG AAGAAAATTA GAGTAGTTAT GTGATTATTT CAGCTCTTGA CCTGTCCCCT 781 CTGGCTGCCT CTGAGTCTGA ATCTCNCAAA GAGAGAAACC AATTTCTAAG ANGANTGGAT 841 TGCAGAAGAN TCGGGGNNAA CATTTGATCC NAGATCTTAA ATGNTATATT GATAANNNTG 901 CTCAGCAATG AGCTATTAGA NTCATTTTGG GAAATCTNNN TNNTTTCNNN TTGTAAACTT 961 NGNTNANNNN NGNCTANNTT NNNATATGNG NGNNNNTTNN NTNANNNNNN NNNN // |
Primer: SV40pA_R (Pr0882) Region: SV40 pA,insert 3' Sequence file: RDB15800_A8Bqb.seq ![]() |
>15800_15800_B0JdF_SV40pA_R_A03_01_ABI08.ab1 1 NNNNNNNNNN NNNNNNNNNT TNNNNAATAA AGCATTTTTT TCNCTGCATT CTAGTTGTGG 61 TTTGTCCAAA CTCATCAATG TATCTTATCA TGTCTGCTCG AAGCGGCCGC CCCAAGGGGT 121 TATGCTAGTT ATTGCTCAGC GGTGGCAGCA GCCAACTCAG CTTCCTTTCG GGCTTTGTTA 181 GCAGCCGGAT CAGCTTGCAT GCCTGCAGGT CGACTCTAGA TTCTATGGGT TGCAATGTTT 241 AGAACATTTT ATTAAAGTAC AAAATTGTTG GAATTTAGCT AATAGAAAAA CATAGTAAAT 301 ATTTACAAAA ACGTTGATAA CATTACTCAA GTCACACACA TATAACAATG TAGACAGGTC 361 TTAACAAAGT TTACAAATTG AAATTATGGA GATTTCCCAA AATGAATCTA ATAGCTCATT 421 GCTGAGCATG GTTATCAATA TAACATTTAA GATCTTGGAT CAAATGTTGT CCCCGAGTCT 481 TCTGCAATCC AGTCCTCTTA GAAATTGGTT TCTCTCTTTG GGAGATTCAG ACTCAGAGGC 541 AGCCAGAGGG GACAGGTCAA GAGCTGAAAT AATCACATAA CTACTCTAAT TTTCTTCATT 601 CTATTGACTG TGTCAAGTTA TAGACACAGC CNAAGTGNTT TTCTTCGGCC TCTGATGATT 661 TGAGAAGANG AANNANATGA GCAATTTCTN NTNGCTTNAA GAAAAANNNN NNNNNTNNNA 721 NNNNNNNNNN // |
Primer: SV40pro_F (Pr0110) Region: hRluc 5' Sequence file: RDB15800_A8Bqc.seq ![]() |
>D05196A7-4_A8Bq_SV40pro_F_G01_2018-03-19-14-24-28_19.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNGT GNNGNNGNTT TTTTGGAGGC CTAGGCTTTT 61 GNNNNNAGCT TGATTCTTCT GACNCNNNNN NCTCGAACCA AAGGCTGGAG CCACCATGGC 121 TTCCAAGGTG TACGACCCCG AGCAACGCAA ACGCATGATC ACTGGGCCTC AGTGGTGGGC 181 TCGCTGCAAG CAAATGAACG TGCTGGACTC CTTCATCAAC TACTATGATT CCGAGAAGCA 241 CGCCGAGAAC GCCGTGATTT TTCTGCATGG TAACGCTGCC TCCAGCTACC TGTGGAGGCA 301 CGTCGTGCCT CACATCGAGC CCGTGGCTAG ATGCATCATC CCTGATCTGA TCGGAATGGG 361 TAAGTCCGGC AAGAGCGGGA ATGGCTCATA TCGCCTCCTG GATCACTACA AGTACCTCAC 421 CGCTTGGTTC GAGCTGCTGA ACCTTCCAAA GAAAATCATC TTTGTGGGCC ACGACTGGGG 481 GGCTTGTCTG GCCTTTCACT ACTCCTACGA GCACCAAGAC AAGATCAAGG CCATCGTCCA 541 TGCTGAGAGT GTCGTGGACG TGATCGAGTC CTGGGACGAG TGGCCTGACA TCGAGGAGGA 601 TATCGCCCTG ATCAAGAGCG AAGAGGGCGA GAAAATGGTG CTTGAGAATA ACTTCTTCGT 661 CGAGACCATG CTCCCAAGCA AGATCATGCG GAAACTGGAG CCTGAGGAGT TCGCTGCCTA 721 CCTGGAGCNN TTCAAGGAGA AGGGCGAGGT TAGACGGCCT ANCCTCTCCT GNCCTCGCGA 781 NATCCCTCTC GTTAAGGGAN GCAAGCCCGA CGTCGTCCAG ATTGTCCGCA ACTACNACGN 841 CTACCTTCGG GCCANCGNCG ATCTGCCTAA GATGTTCATC GANTCCGANC CNGGGTTCTT 901 TTNCNNCNCT ATTGTCNAGG GNNCTNAGAN NTTCCCTAAC NNNNNNTTCG TGNNNNNGNN 961 NGNNNTNNNN TTCAGCNNNN NNNNNN // |
Primer: Neo-M_R (Pr0145) Region: NeoR 5',hRluc 3' Sequence file: RDB15800_A8Bqd.seq ![]() |
>D05196A7-4_A8Bq_Neo-M_R_A02_2018-03-19-14-24-28_02.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNTNNNNNT TNNGTGACNA CGTCGAGCAC AGCTGCGCAA 61 GGAACGCCCG TCGTGGCCNG CCACGATAGC CGCGCTGCCT CGTCCTGCAG TTCATTCAGG 121 GCACCGGACA GGTCGGTCTT GACAAAAAGA ACCGGGCGCC CCTGCGCTGA CAGCCGGAAC 181 ACGGCGGCAT CAGAGCAGCC GATTGTCTGT TGTGCCCAGT CATAGCCGAA TAGCCTCTCC 241 ACCCAAGCGG CCGGAGAACC TGCGTGCAAT CCATCTTGTT CAATCCCTCC GGAGCCTCCG 301 CCACCTGATC CGCCACCTCC GCTCCCACCA CCGGTCTGCT CGTTCTTCAG CACGCGCTCC 361 ACGAAGCTCT TGATGTACTT ACCCATTTCA TCTGGAGCGT CCTCCTGGCT GAAGTGGAGG 421 CCCTTCACCT TCACGAACTC GGTGTTAGGG AACTTCTTAG CTCCCTCGAC AATAGCGTTG 481 GAAAAGAACC CAGGGTCGGA CTCGATGAAC ATCTTAGGCA GATCGTCGCT GGCCCGAAGG 541 TAGGCGTTGT AGTTGCGGAC AATCTGGACG ACGTCGGGCT TGCCTCCCTT AACGAGAGGG 601 ATCTCGCGAG GCCAGGAGAG GGTAGGCCGT CTAACCTCGC CCTTCTCCTT GAATGGCTCC 661 AGGTAGGCAG CGAACTCCTC ANGCTCCAGT TTCCGCATGA TCTTGCTTGG GAGCATGGTC 721 TCGACGAAGA AGTTATTCTC AAGCACCATT TTCTCGCCCT CTTCGCTCTT GATCAGGGCG 781 ATATCCTCCT CNATGTCANG NCACTCGTCC CAGGANTCNA TCACGTNCAC GANACTCTCA 841 GCATGGACNA TGGNCTTGAT CTTGNCTTGG NGCNCGTNNN ANTAGTGAAA NGNNCAGANN 901 AGCCCCCCNN GNNNNNNNNC NNNNGNTGAT TTNCNTNNGN NNNNNNANCA GNNNNNNCCN 961 AGCNNNNANG NNNNNNNNNN // |
Primer: PGKpro_F (Pr0249) Region: Luc2 5' Sequence file: RDB15800_A8Bqe.seq ![]() |
>D05196A7-4_A8Bq_PGKprp_F_C02_2018-03-19-14-24-28_08.ab1 1 NNNNNNNNNN NNNNNNNNNN NNTCTCCNGG CCTTTCGNNC TGCAGCCCAA GCTTGGCAAT 61 CCGGTACTGT TGGTANAGCC ACCATGGAAG ATGCCAAAAA CATTAAGAAG GGCCCAGCGC 121 CATTCTACCC ACTCGAAGAC GGGACCGCCG GCGAGCAGCT GCACAAAGCC ATGAAGCGCT 181 ACGCCCTGGT GCCCGGCACC ATCGCCTTTA CCGACGCACA TATCGAGGTG GACATTACCT 241 ACGCCGAGTA CTTCGAGATG AGCGTTCGGC TGGCAGAAGC TATGAAGCGC TATGGGCTGA 301 ATACAAACCA TCGGATCGTG GTGTGCAGCG AGAATAGCTT GCAGTTCTTC ATGCCCGTGT 361 TGGGTGCCCT GTTCATCGGT GTGGCTGTGG CCCCAGCTAA CGACATCTAC AACGAGCGCG 421 AGCTGCTGAA CAGCATGGGC ATCAGCCAGC CCACCGTCGT ATTCGTGAGC AAGAAAGGGC 481 TGCAAAAGAT CCTCAACGTG CAAAAGAAGC TACCGATCAT ACAAAAGATC ATCATCATGG 541 ATAGCAAGAC CGACTACCAG GGCTTCCAAA GCATGTACAC CTTCGTGACT TCCCATTTGC 601 CACCCGGCTT CAACGAGTAC GACTTCGTGC CCGAGAGCTT CGACCGGGAC AAAACCATCG 661 CCCTGATCAT GAACAGTAGT GGCAGTACCG GATTGCCCAA GGGCGTAGCC CTACCGCACC 721 GCACCGCTTG TGTCCGATTC AGTCATGCCC GCGACCCCAT CTTCGGCAAC CAGATCATCC 781 CCGACACCGC TATCCTCAGC GTGGTGCCAT TTCACNACGG CTTCGGCATG TTCACCACGC 841 NNGGCTACTT GATCTGCGGC TTTCGGGNCG TGCTCATGTA CCGCTTCNAG GANGANCTAT 901 TCTTGCGCAG CTNGNNNGAN TATAANATTN NNTCTGNCNN NCNNGNNNCC ACNCTATTTN 961 NCNNNNTCNC NNANNNCNNN NNNATCNNNN NNNNNN // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
original | Deguchi, S., Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis. Oncogene 36 (32): 4629-4640 (2017). PMID 28368417. [link to RRC of NBRP] |
---|
Featured content